References
- Glanemann M, Shi B, Liang F, et al. Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol. 2008;6:123.
- Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–1137.
- Schwartz SI. Biliary tract surgery and cirrhosis: a critical combination. Surgery. 1981;90(4):577–583.
- Doberneck RC, Sterling WA, Jr., Allison DC. Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg. 1983;146(3):306–309.
- Garrison RN, Cryer HM, Howard DA, et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg. 1984;199(6):648–655.
- Aranha GV, Greenlee HB. Intra-abdominal surgery in patients with advanced cirrhosis. Arch Surg. 1986;121(3):275–277.
- Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90(1):42–53.
- Mansour A, Watson W, Shayani V, et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery. 1997;122(4):730–736.
- Belghiti J, Gillet M, Congrès Français de Chirurgie. La chirurgie digestive chez le cirrhotique: rapport présenté au 95e congrès français de chirurgie. Paris: Springer Verlag; 1993.
- Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213.
- Cobb W, Heniford B, Burns J, et al. Cirrhosis is not a contraindication to laparoscopic surgery. Surg Endosc. 2005;19(3):418–423.
- Gil A, Martínez-Regueira F, Hernández-Lizoain JL, et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol. 2004;30(1):46–52.
- Bhangui P, Laurent A, Amathieu R, et al. Assessment of risk for non-hepatic surgery in cirrhotic patients. J Hepatol. 2012;57(4):874–884.
- Sethi H, Srinivasan P, Marangoni G, et al. Pancreaticoduodenectomy with radical lymphadenectomy is not contraindicated for patients with established chronic liver disease and portal hypertension. Hepatobiliary Pancreat Dis Int. 2008;7(1):82–85.
- Warnick P, Mai I, Klein F, et al. Safety of pancreatic surgery in patients with simultaneous liver cirrhosis: a single center experience. Pancreatology. 2011;11(1):24–29.
- Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years After. Surgery. 2017;161(3):584–591.
- Gillen S, Schuster T, Meyer Zum Büschenfelde C, et al. Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7(4):e1000267.
- He J, Cameron JL, Ahuja N, et al. Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg. 2013;216(4):657–667.
- Uchida H, Shibata K, Kai S, et al. Pylorus-preserving pancreaticoduodenectomy in patients undergoing chronic hemodialysis. Surg Today. 2008;38(12):1152–1154.
- Friedman LS, Maddrey WC. Surgery in the patient with liver disease. Med Clin North Am. 1987;71(3):453–476.
- Runyon BA. Surgical procedures are well tolerated by patients with asymptomatic chronic hepatitis. J Clin Gastroenterol. 1986;8(5):542–544.
- Hargrove MD. Jr. Chronic active hepatitis: possible adverse effect of exploratory laparotomy. Surgery. 1970;68(5):771–773. Nov
- Mariette D, Belghiti J. Chirurgie due pancreas et cirrhose. In: Belghiti J, Gillet M, editors. La chirurgie digestive chez le cirrhotique. Paris: Monographies de l’AFC; 1993. p. 105–112.
- Belli G, Fantini C, Ciciliano F, et al. Pancreaticoduodenectomy in portal hypertension: use of the ligasure. J Hepatobiliary Pancreat Surg. 2003;10(3):215–217.
- Azoulay D, Buabse F, Damiano I, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg. 2001;193(1):46–51.
- Northup PG, Wanamaker RC, Lee VD, et al. Model for End-Stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242(2):244–251.
- Rice HE, O’Keefe GE, Helton WS, et al. Morbid prognostic features in patients with chronic liver failure undergoing nonhepatic surgery. Arch Surg. 1997;132(8):880–885.
- Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–470.